Tiotropium is a medicine used to help keep the airways open in people with a lung condition called COPD. It's often taken once a day as an inhaler. It works by relaxing the muscles around the airways, making it easier to breathe.
Every report comes from a Lived member, sent anonymously.
Have you tried Spiriva (Tiotropium) for COPD?
Tiotropium, best known by the brand name Spiriva, is an inhaled medicine that keeps the airways open over the long term. It is used once a day as maintenance treatment for chronic obstructive pulmonary disease (COPD), the lung disease that includes emphysema and chronic bronchitis. In COPD it eases day-to-day breathlessness and also lowers the chance of flare-ups, the periods when breathing, cough and mucus get markedly worse and may need steroids, antibiotics or a hospital stay. Spiriva comes in two inhaler types. Spiriva HandiHaler, a dry powder in capsules, is approved for COPD only; a generic version is also available. Spiriva Respimat, a soft mist spray, is approved for COPD and also for asthma in people 6 and older, where it is added to an inhaled steroid when asthma is not well controlled. Tiotropium is also one of the two ingredients in Stiolto Respimat, a COPD-only combination inhaler that is not used for asthma.
The muscles that wrap around the airways tighten in response to acetylcholine, a chemical messenger released by nerves. In COPD this nerve signal is a major reason the airways stay narrowed. Tiotropium belongs to a group of medicines called long-acting anticholinergics (also called antimuscarinics): it blocks the receptors acetylcholine acts on in the airway muscle, so the muscle relaxes and the airways widen. Because tiotropium stays attached to these receptors for more than a day, one dose gives a steady effect around the clock. Most of the medicine acts directly in the lungs, where it is inhaled, rather than throughout the body. It widens the airways but does not repair lung damage or slow the long-term decline of lung function in COPD.
Each daily dose is two inhalations, taken once a day at about the same time. With the HandiHaler, one capsule goes into the device, a button pierces it, and you breathe the powder in twice from that same capsule. The capsules are only for this device and must never be swallowed, because swallowing them does not deliver the medicine to the lungs. With the Respimat, the dose is two puffs of the spray; a new cartridge has to be inserted and the inhaler primed by spraying it toward the ground before first use, and again after it has not been used for a few days. The COPD and asthma Respimat inhalers contain different strengths, so use only the one prescribed. Tiotropium is not a rescue inhaler. It works too slowly to relieve a sudden attack of breathlessness or wheezing, so you still need a fast-acting rescue inhaler such as albuterol for that. Do not take more than one dose in 24 hours, even on a bad day; if you need your rescue inhaler more often than usual, tell your care team. Inhaler technique matters, so it is worth having a clinician or pharmacist watch you use it.
Dry mouth is the most common side effect; it is usually mild and often fades with continued use. Sore throat, cough and sinus irritation are also common. Less often, the medicine's drying effect causes constipation, a faster heartbeat or blurred vision. Getting powder or spray in your eyes can blur vision and widen the pupil, so aim carefully. Rarely, an inhaled medicine causes the airways to tighten instead of relax. If your wheezing or breathing gets worse right after a dose, use your rescue inhaler, stop tiotropium and contact your care team promptly; get emergency help if your breathing does not improve. Swelling of the lips, tongue or throat, hives or trouble breathing after a dose can signal a serious allergic reaction and needs emergency care.
Tiotropium is not used by people who are allergic to it or to ipratropium, an older, closely related inhaled medicine. People who have reacted to atropine (a related anticholinergic medicine used in some pupil-widening eye drops and given by injection in hospital care, such as around surgery) should be watched closely, and the HandiHaler powder contains lactose, so people with severe milk protein allergy need to discuss it with their prescriber. Tiotropium can worsen two conditions. In narrow-angle glaucoma, where fluid cannot drain properly from the eye, it can raise eye pressure. In anyone using tiotropium, and especially with known narrow-angle glaucoma, eye pain, blurred vision, halos around lights or red eyes need immediate contact with a doctor. In people who already have trouble emptying the bladder, such as men with an enlarged prostate, it can make urinating harder; difficulty passing urine or painful urination also need prompt attention. People with moderate to severe kidney disease clear the medicine more slowly and should be watched for these effects. Avoid combining tiotropium with other anticholinergic medicines, which add to these effects. Examples include ipratropium and umeclidinium (Incruse Ellipta), another once-daily COPD inhaler of the same type. Many combination COPD inhalers already contain this type of medicine, so make sure your prescriber knows every inhaler you use. By contrast, tiotropium can be used alongside other common breathing medicines, including albuterol, long-acting beta-agonist inhalers (a different type of airway-relaxing medicine, a longer-lasting relative of albuterol) and inhaled steroids. Data on pregnancy are limited, so anyone pregnant or planning pregnancy should weigh it with their prescriber, keeping in mind that poorly controlled asthma also carries risks.
In COPD, airflow improves within hours of the first dose and builds further over the first week of daily use. Many people notice it as somewhat easier breathing during everyday activities, though the change is often gradual rather than dramatic. The reduction in flare-ups shows up over months: in a four-year study, the typical person taking tiotropium had a first flare-up about four months later than people taking a placebo (around 17 months rather than 12 and a half), so flare-ups became less frequent but did not stop. In asthma, the full benefit on lung function can take four to eight weeks. Tiotropium only helps while it is taken every day, so it is a long-term treatment rather than something used when symptoms appear. It does not cure COPD or stop it from progressing, and if breathlessness or flare-ups continue, some people need a long-acting beta-agonist or an inhaled steroid added, sometimes by switching to a combination inhaler that includes tiotropium or a similar medicine rather than using it on top. Regular follow-up visits are a chance to review symptoms, flare-ups, rescue inhaler use and inhaler technique.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Spiriva (Tiotropium), what you've noticed, or ask the community a question.